Preclinical characterization of allogeneic CAR ?d T Cell therapy for prostate cancer targeting a novel dimeric epitope on PSMA

被引：0
|
作者：
Ramadoss, Nitya S.
Speltz, Elizabeth
Capillo, Tonya
Meaddough, Erika
Wang, Katherine
Friedland, Natalia
Wong, Jonathan
Teague, Alexander G.
Azameera, Aruna
Gundurao, Smitha Rao Yelaguli
Kaur, Ramandeep
Smith-Boeck, Morgan
Salum, Michael
Chanthery, Yvan
Green, Shon
Herrman, Marissa
Nishimoto, Kevin P.
Aftab, Blake T.
Bhat, Arun
机构：
来源：
MOLECULAR CANCER THERAPEUTICS | 2023年 / 22卷 / 12期
关键词：
D O I：
10.1158/1535-7163.TARG-23-C117
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
C117
引用
收藏
页数：2
相关论文
共 50 条
  • [1] PRECLINICAL DISCOVERY AND CHARACTERIZATION OF ALLOGENEIC ANTI-PSMA γδ CAR T THERAPY FOR PROSTATE CANCER
    Ramadoss, Nitya
    Azameera, Aruna
    Teague, Alexander
    Wong, Jonathan
    Bagchi, Atrish
    Capillo, Tonya
    Smith-Boeck, Morgan
    Salum, Michael
    Meaddough, Erika
    Speltz, Elizabeth
    Hoopes, Matthew
    Wang, Katherine
    Kaur, Ramandeep
    Gundurao, Smitha
    Herrman, Marissa
    Chanthery, Yvan
    Aftab, Blake
    Nishimoto, Kevin
    Bhat, Arun
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A216 - A216
  • [2] PSMA targeting CAR T cell immunotherapeutic strategy for prostate cancer.
    Gonzalez-Valdivieso, Juan
    Yang, Yanping
    Vedvyas, Yogindra
    Alcaina, Yago
    Jin, Moonsoo M.
    CANCER RESEARCH, 2022, 82 (12)
  • [3] Allogeneic CAR T Cell Therapy for Cancer
    Sasu, Barbra Johnson
    Lauron, Elvin James
    Schulz, Thomas
    Cheng, Hsin-Yuan
    Sommer, Cesar
    ANNUAL REVIEW OF CANCER BIOLOGY, 2024, 8 : 227 - 243
  • [4] TARGETING SENESCENT CELLS IN PROSTATE CANCER USING CAR T CELL THERAPY
    Kohl, A.
    Bressan, S.
    Dutoit, V.
    Alimonti, A.
    Migliorini, D.
    HUMAN GENE THERAPY, 2023, 34 (21-22) : A40 - A41
  • [5] The potential of CAR T cell therapy for prostate cancer
    Philipp Wolf
    Jamal Alzubi
    Christian Gratzke
    Toni Cathomen
    Nature Reviews Urology, 2021, 18 : 556 - 571
  • [6] The potential of CAR T cell therapy for prostate cancer
    Wolf, Philipp
    Alzubi, Jamal
    Gratzke, Christian
    Cathomen, Toni
    NATURE REVIEWS UROLOGY, 2021, 18 (09) : 556 - 571
  • [7] Preclinical Development of CTX120, an Allogeneic CAR-T Cell Targeting Bcma
    Dar, Henia
    Henderson, Daniel
    Padalia, Zinkal
    Porras, Ashley
    Mu, Dakai
    Kyungah, Maeng
    Police, Seshidhar
    Kalaitzidis, Demetrios
    Terrett, Jonathan
    Sagert, Jason
    BLOOD, 2018, 132
  • [8] Preclinical Development of Novel PSMA-Targeting Radioligands: Modulation of Albumin-Binding Properties To Improve Prostate Cancer Therapy
    Umbricht, Christoph A.
    Benesova, Martina
    Schibli, Roger
    Muller, Cristina
    MOLECULAR PHARMACEUTICS, 2018, 15 (06) : 2297 - 2306
  • [9] 7 PROSTATE CANCER Developing CAR T cell therapy
    Thoma, Clemens
    NATURE REVIEWS UROLOGY, 2018, 15 (03) : 138 - 138
  • [10] Allogeneic CAR T Cells Targeting DLL3 Are Efficacious and Safe in Preclinical Models of Small Cell Lung Cancer
    Zhang, Yi
    Tacheva-Grigorova, Silvia K.
    Sutton, Janette
    Melton, Zea
    Mak, Yvonne S. L.
    Lay, Cecilia
    Smith, Bryan A.
    Sai, Tao
    Van Blarcom, Thomas
    Sasu, Barbra J.
    Panowski, Siler H.
    CLINICAL CANCER RESEARCH, 2023, 29 (05) : 971 - 985
12345